Celularity Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CELU?
Owner TypeNumber of SharesOwnership Percentage
Private Companies190,9150.797%
Individual Insiders3,240,84113.5%
Institutions3,512,30814.7%
General Public8,172,28034.1%
Public Companies8,832,88536.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 65.19% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.5%
Genting Berhad
6,335,630US$11.7m0%no data
11.9%
Robert Hariri
2,854,735US$5.3m0.19%no data
6.38%
Starr International Investments Limited
1,528,139US$2.8m0%72.76%
4.99%
Bristol-Myers Squibb Company
1,195,327US$2.2m0%no data
3.33%
United Therapeutics Corporation
796,885US$1.5m0%no data
3.19%
C.V. Starr & Co., Inc., Asset Management Arm
764,069US$1.4m0%1.02%
2.11%
Sorrento Therapeutics, Inc.
505,043US$934.3k0%no data
2.09%
The Vanguard Group, Inc.
500,132US$925.2k0%no data
0.8%
GX Sponsor LLC
190,915US$353.2k1,810%no data
0.57%
Geode Capital Management, LLC
136,041US$251.7k3.45%no data
0.56%
Peter Diamandis
134,307US$248.5k-32.2%no data
0.54%
Dean Kehler
130,461US$241.4k-52.7%no data
0.42%
BlackRock, Inc.
101,180US$187.2k-0.46%no data
0.27%
State Street Global Advisors, Inc.
65,430US$121.0k0%no data
0.2%
National Bank Investments Inc.
48,000US$88.8k0%no data
0.2%
Citadel Advisors LLC
46,946US$86.8k0%no data
0.17%
HB Wealth Management, LLC
40,763US$75.4k1.65%no data
0.15%
Two Sigma Investments, LP
36,380US$67.3k-19%no data
0.15%
Biltmore Family Office, LLC
35,000US$64.7k0%0.01%
0.14%
Northern Trust Global Investments
34,062US$63.0k0%no data
0.12%
John Haines
29,121US$53.9k3.79%no data
0.12%
Marc Mazur
28,500US$52.7k0%no data
0.11%
Group One Trading LP, Asset Management Arm
26,243US$48.6k58.2%no data
0.1%
Keynote Financial Services, LLC
25,023US$46.3k0%0.03%
0.099%
Diane Parks
23,607US$43.7k-74.1%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/30 01:10
End of Day Share Price 2025/06/30 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Celularity Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Thomas ShraderBTIG
Swayampakula RamakanthH.C. Wainwright & Co.